A bespoke, go-to resource for patients, clinicians, researchers, and health policy specialists
Know Your Code is a genetic testing advocacy initiative by Retina International and is part of a call to action for the Inherited Retinal Degeneration (IRD) community to advocate for affordable and accessible genetic testing to accurately diagnose IRDs.
What is Know Your Code?
Know Your Code is Retina International’s genetic testing advocacy initiative, promoting affordable and accessible genetic testing for people affected by inherited retinal diseases (IRDs).
The platform provides information and resources for patients, clinicians, researchers and health policy specialists on genetics and inheritance, genetic testing, genetic counselling, and global access to testing.
Explore the resources to understand genetic testing, prepare for testing, learn about research findings and advocate for equitable access to genetic services.
Genetics Key Facts
What is DNA?
Our cells are protein making factories. Deoxyribonucleic acid (DNA) is the instruction manual that tells our cells the shape, size, and function of each protein that it makes. Each protein is coded by its own little section of DNA called a gene.
DNA is made up of building blocks called nucleotides. There are 4 different kinds of blocks: Adenine (A), Thymine (T), Guanine (G) & Cytosine (C). The specific order of these nucleotides in a gene forms the instructions, or code, for the cell to follow – like the words of a sentence.
The same way that binary numbers (0 and 1) can encode all our technology, and the 26 letters of the alphabet make up all the words in the English language, the language of our genome, i.e. the complete set of genes in a cell, consists of only 4 characters: A, T, G & C.
Image: “DNA, Chromosomes and Genes” by National Institutes of Health (NIH) is licensed under CC BY-NC 2.0
What is a mutation?
Some genes remain the same across all humans (and lots of different animal species too!); for example, most of us have two arms, two legs, two eyes, ten fingers & toes, a heart, a liver, etc.
However, there are parts of your genome that are unique to you and your family. These differences are what make you different from everyone else in the world; the shape of your nose, the freckles on your face, your height, hair colour, and much more!
These differences are called mutations, and most of the time they are completely harmless. At some point in the past, nucleotides in the DNA were added, removed, or swapped, thus changing the gene slightly.
If we relate the our genes back to sentences in a book, a mutation is like when there is a misspelling in a word. Sometimes, a change in spelling will not change the meaning of a word:
E.g.: Color –> Colour
In this case, the ‘u’ has been added, but one can still recognise the word as meaning the same thing – in fact, many people use “colour” all the time!
In other cases, a mutation can change the meaning of a gene completely:
E.g. Decrease –> Increase
Here, the “De” has been swapped for “In”, and the meaning of the word has now changed completely. If this mistake was part of an instruction manual, one would be doing the complete opposite of what they should. When these kinds of mistakes or mutations happen in the DNA of a cell, it can have a negative effect on how the cell functions.
What is an IRD?
Sometimes, when genetic mutations have a negative effect, the resulting protein that your cell makes doesn’t work the way it’s supposed to. This can have drastic downstream effects on the overall function of a cell.
For example, a genetic mutation in a waste-disposing protein might stop it from working properly. In this case, if a cell cannot get rid of its waste, it will eventually die.
When genetic mutations affect the way the cells of the retina work, the cells begin to deteriorate. Over time, this results in a progressive loss of vision. These conditions are called Inherited Retinal Degenerations, or IRDs.
There are many different kinds of IRDs, with hundreds of mutations that can cause them. Knowing your code, or mutation, can help researchers understand exactly what is happening in your cell; which protein is not acting how it should, and if there is a way to slow down, stop, or reverse the process.
If you would like to learn more about IRDs, visit our page here.
Inheritance
When mutations are passed down from parent to child, we call it inheritance. The type of mutation, and where it occurs in the genome can influence the probability that it will be inherited.
To explore this, we must first understand how our genome is created.
The creation of a new genome
DNA is stored in densely packed structures called chromosomes. There are 23 pairs of chromosomes in a cell – so 46 in total. This is true for each type of cell in your body, bar one – your gametes.
An individual will make one of two kinds of gametes – sperm, or ova (eggs). Gametes have only 23 chromosomes, one from each pair, and are made through a process called meiosis. During meiosis, the pairs of chromosomes swap chunks of DNA with one another in a process called crossover, thus making a new, random assembly of DNA. These new chromosomes then split into separate gamete cells, to be inherited by the individuals offspring.
Upon fusion of a sperm and ovum, a zygote is created. Each of the gamete’s 23 chromosomes will find its pair, creating a new 46 chromosome genome. The zygote then starts dividing rapidly, creating exact copies of this new genome that will go on to form life.
X & Y Chromosomes
Of the 23 pairs of chromosomes, one pair are called “sex chromosomes”. A biological female will have two X chromosomes (XX), while a biological male will have an X and Y chromosome (XY). An XX individual will mature to have female sex organs, and produce ova. An XY individual will mature to have male sex organs, and produce sperm. Since XX individuals only have one type of sex chromosome, their ova gametes will always have an X chromosome. When an XY individual’s sperm cells are being made, the gamete may retain either an X or Y chromosome during meiosis.
If a sperm cell containing an X chromosome fuses with an ovum, an XX biologically female zygote will be formed. If a sperm cell containing a Y chromosome fuses with an ovum, an XY biologically male zygote will be formed. This information is important when discussing X-linked genetic conditions, which will be explored later.
Alleles
An allele is simply a variant of a specific gene. If genes were like cars, then the alleles would be all the different makes and models – each allele, or variant of a gene, serves the same purpose, it just looks slightly different.
Because one chromosome in each of your 23 pairs comes from a separate parent, you will have two alleles of each gene in your cell. These alleles may be the same, or different, depending on your parents’ genetics and what DNA you inherited from them.
This serves an evolutionary purpose, as whichever allele is the “strongest” or more dominant, the cell will express, or make protein from. “Weaker” or recessive genes are not expressed. The logic behind this is that the cell is selecting the optimum performance options from the available selection in the genome.
Inheritance patterns
Depending on where a mutation is located, and the kind of mutation it is, influences the likelihood of:
- Inheriting the mutation
- Being affected by the genetic condition as a result
For this reason, it is very useful for patients to understand the inheritance pattern of their mutation, so as to identify the risk of other family members having inherited the same mutation.
Below are some of the most commonly seen inheritance patterns.
Autosomal Dominant Inheritance
When a mutation in a dominant allele is inherited, the cell will always express the mutated gene, and that individual will show symptoms of that particular genetic condition. We typically refer to this person as an “affected” individual.
So, when gametes are being made, and the chromosome pairs split into separate gametes, 50% of them will have the chromosome with the mutated dominant allele, and 50% will have the other, recessive allele. If an offspring inherits the dominant allele, they will be affected by the genetic condition, and be at risk of passing the mutation on to their own progeny. If they inherit the recessive allele, the individual will be unaffected, and have 0% risk of passing the mutation on.
To learn more about Autosomal Dominant Inheritance, click here to view a video by the Genomics Education Programme (NHS).
Autosomal Recessive Inheritance
When a mutation in a recessive allele is inherited, the cell will not express that mutation in the presence of an unmutated allele, as the unmutated allele will be dominant. As such, protein is made from the DNA of the unmutated allele, and the individual shows no symptoms. This person is however what we refer to as a “carrier” – someone who is not affected by the genetic condition themselves, however can still pass the mutated allele on to offspring. As before, 50% of the individual’s gametes will possess the mutant recessive allele.
If both parents are carriers, and their offspring inherits the mutated recessive allele from both parents, then that offspring’s cells will have no option but to express the recessive allele and as such will be affected. In the case of two carrier parents, there is a 25% probability that their offspring will inherit both recessive alleles be affected by the condition. There is also a 25% probability that the offspring will inherit both dominant alleles, and will not carry the gene. The remaining 50% accounts for offspring that have inherited one dominant and one recessive gene from their parents. These offspring will be carriers, akin to their parents.
If only one parent is a carrier, there is 0% risk of their offspring developing genetic disease, however there is a 25% probability that their offspring will inherit the recessive allele from the carrier parent, and become a carrier themselves.
To learn more about Autosomal Recessive Inheritance, click here to view a video by the Genomics Education Programme (NHS).
X-linked recessive inheritance
Earlier we discussed X & Y sex chromosomes. Here we will explore how inheritance of mutations in these chromosomes differs from the other 22 pairs of chromosomes. When a genetic condition is X-linked recessive, that means that the mutation lies on the X chromosome, and primarily affects XY males, due to them possessing only one X chromosome.
If an XY male inherits a mutated X chromosome from their XX mother, they will develop the condition, because the Y chromosome does not possess an allele for that gene, and cannot prevent the cell from expressing the affected X chromosome. In the case of an XX carrier mother, and an unaffected XY father, offspring have a 50% risk of inheriting the affected chromosome. XY sons that inherit the mutated X chromosome will be affected by the genetic condition, while XX daughters will be unaffected carriers.
For XX females to be affected, both of their X chromosomes must have the mutated gene. One must come from an affected XY father and one from an XX carrier mother. However, due to a phenomenon called non-random X chromosome inactivation, female carriers may display some symptoms of the disease.
Mitochondrial inheritance
A small amount of our genome lies outside of chromosomes, in what we call mitochondrial DNA, Mitochondrial inheritance, also referred to as maternal inheritance applies specifically to genes contained within mitochondrial DNA.
Mitochondria are structures found within cells and responsible for producing energy for the cell. Egg cells and not sperm cells contribute mitochondria to a developing embryo and explains why only XX females can pass mitochondrial mutations to their children. These conditions can affect both males and females and can appear in every generation of a family, but XY fathers cannot pass down these conditions to their children.
The severity of symptoms may vary from one affected individual to another; even within the same family due to a ‘dosage’ effect. This is due to the fact that we have many mitochondria in each cell. In one individual, if only a small proportion of mitochondria in each cell have the mutation, symptoms will be mild. In another individual, if a higher proportion of mitochondria in each cell carry the mutation, symptoms will be more severe.
This short audio-visual by Children’s national Hospital Rare Disease Institute helps to explain the phenomenon of Mitochondrial inheritance: Mitochondrial Inheritance.
Uncertain Inheritance
Very often, a person diagnosed with an inherited condition has no other family members with the disease. There are several possible reasons for only finding one person affected in the family:
- The mutation may be a new event in that person,
- Other family members may have the same mutation, but may have not yet been diagnosed with the condition.
- Other family members may have a later age of onset, or have milder signs of the disease.
The mutation might also have been in the family for a long time, but by chance, no other family members have been affected. For autosomal recessive disease, carriers may have been present in the mother’s and father’s side of the family for several generations, but a child won’t develop a condition unless both parents are carriers and both pass on a mutation to their child.
About Genetic Testing
Why test?
Nearly 300 IRD-associated genes have now been discovered, yet this only yet this only permits for definitive genetic diagnoses for 2 of every 3 IRD patients. Routine affordable and accessible genetic testing will fast-track the discovery of the remaining genes, and pave the way for therapeutic intervention for everyone affected by IRDs.
Further considerations regarding genetic testing - benefits:
Benefits:
- A genetic test has the potential to identify the exact cause of an IRD.
- It allows people to adjust their lifestyle and manage their particular condition as well as possible.
- Receiving an accurate diagnosis makes it possible for an individual to participate in appropriate clinical trials and allows for access to relevant treatments, should they become available. These opportunities are only available to those who have undergone a genetic test.
- The results of a genetic test can also be stored on a register that will help to not only populate clinical trials in the future, but help researchers to better understand the molecular basis of the condition.
- For some, the results of a genetic test can assist in family planning decisions. Being aware that there is an increased risk of having a child with an IRD can also allow you to talk with your doctor to best plan for your future and prepare yourself, should you choose to have a family.
- As most genetic conditions are inherited and affects many generations of a family, information about your genetic makeup (genotype) can be useful to other family members. For example, in some cases the risk of having a baby with a retinal dystrophy is not for the affected person but for a relative, which is evident in IRDs that have an X-linked pattern of inheritance.
Limitations
Emotional burden
It must be emphasised that taking a genetic test, waiting for, and ultimately receiving the results can be a very stressful and emotional experience for an individual and their family. Those who are eventually diagnosed with IRDs often describe the actual diagnosis as a relief, because they now have a definitive answer and feel empowered to make informed life decisions. However, some have also described feelings of anxiety and guilt, particularly when disease-causing mutations have been passed on to their children. With this in mind, it is crucial to talk through the possible outcomes, be they positive or negative, of a genetic test with your loved ones. Support is also available to you through your genetic counsellor.
Limited therapeutic options
As many treatments for IRDs are still in the development phase, a genetically confirmed diagnosis may not lead to an intervention or treatment now or in the future. Although nearly 300 IRD-associated genes have been identified, they provide definitive diagnoses to only 2 of every 3 individuals living with an IRD. It is very important to note that in some cases, the gene(s) responsible for a genetic condition have not been identified. Some genetic mutations are very difficult to find with current laboratory techniques. For those trying to get a diagnosis to enable access to information on inheritance and disease pathways, this can be very frustrating.
Fear of discrimination
While many countries now have legislation protecting individuals from discrimination on account of a genetic diagnosis – particularly with matters such as employment or health insurance, many may be wary of the impact a genetic test may have. These are valid concerns, and we encourage you to discuss any questions you may have with your physician, genetic counsellor, or local advocacy organisation.
What is genetic counselling?
Genetic counsellors
Genetic counsellors are health care professionals with specialist expertise in medical genetics and counselling and work as part of a larger health care team. Seeking their support through a genetic testing process can help alleviate concerns and help you adapt to a genetic diagnosis in the most effective way possible.
What does a genetic counsellor do?
- Assess the risk of a genetic disorder by researching a family’s history, evaluating medical records, and conducting a physical examination of the patient and other family members when indicated.
- Examine and evaluate the impact of genetic testing from a medical, social and ethical perspective in each case.
- Provide the support and information needed to assist an individual and their family in making a decision about genetic testing.
- Interpret the results of genetic tests and medical data.
- Provide counselling or refer individuals and families to support services.
- Advocate for the patient and their family in the healthcare system.
- Explain the next steps for a patient or their family including possible treatments options.
- Discuss life choices including family planning.
- Advise patients on next steps with regard to disclosing their results to family, employers, and/or insurance companies.
Preparing for your Genetic Test
General FAQs
Below are some general questions that may be useful to discuss with your clinical specialist regarding genetic testing:
- Why are you asking me to have a genetic test?
- Why have I or my child been referred to see a genetics specialist?
- Why do I or my child have this condition?
- Can you tell me about the condition I or my child is being tested for?
- How common is this condition?
- What might it be like to live with this condition?
- Is there any treatment for this condition?
- If so, is it expensive and will I have to pay?
- Is everybody with this condition affected by it in the same way?
- How is the condition passed from one generation to the next?
- If I have another child what is the risk that they will have the condition?
- Where can I find more information about the condition?
Questions to ask yourself before a genetic test
- Will the results of the test affect other members of my family and if so, should I discuss the test with them first?
- How might the results of the test affect me and my family emotionally?
- Who should I tell about the test results (e.g. family members, work colleagues, teachers)?
- Will the results affect my insurance?
- Will you be giving me written information that goes over what we have been discussing? (You might want to ask for this if this is not standard procedure).
- Who will be the one to explain the results to my child and/or relatives?
- Is there any written information that you can give me, which will help explain the situation to my child and/or relatives?
- Are there any support services or patient organisations I can contact?
- What other health professionals should I get in contact with?
Health Insurance FAQs and Genetic Discrimination
Despite the many benefits of taking a genetic test, many fear that a positive result will lead to genetic discrimination, particularly with regard to health insurance. It is important that individuals and families have access to genetic testing without fear of discrimination or increasing insurance premiums.
Genetic Information Non-Discrimination Legisation
Many countries have published legislation to address this issue. One of the best known pieces of legislation is the Genetic Information Non-discrimination Act (GINA) in the United States which was passed into law in 2008. GINA prohibits discrimination by employers and health insurers against those with a positive genetic test result, but there are also other legal protections against genetic discrimination by employers, health insurers, and others.
The laws with respect to right to privacy on genetic test results differ in many countries and regions. Retina International strongly recommends that you examine the position in your own country so that you establish how the results of a genetic test could affect your ability to access a mortgage or the impact it might have on an insurance policy.
FAQs regarding health insurance and genetic testing
It is fair to say that although the legislation may vary the concerns at accessing insurance cover following a genetic test are universal, and below are some general FAQs from organisations that advocate for those who live with genetic conditions. Genetic discrimination is illegal in many countries; however, we implore you to contact your local national organisation for further information as necessary.
What if the insurance company has not heard of my condition?
Insurance companies need to understand your condition so they can assess your application. If your condition is not common, the insurance underwriter may want to find out more information from you or your doctors. An insurance company may also consult with their Chief Medical Officer or other qualified experts. Information from your General Practitioner or hospital doctor may also be requested to better understand the risk. The insurance company will always ask for your permission to contact your General Practitioner or hospital doctor.
What if I am an unaffected carrier of a genetic condition?
Being a carrier of a genetic condition but showing no symptoms does not need to be disclosed to the insurance company. However, you must disclose all relevant medical history.
Should I tell my insurance company if I am receiving treatment for a condition?
Explaining current treatment is essential as it shows that the condition is treatable; The insurance company may ask for a letter from your GP or a hospital doctor for further information of the treatment and its effectiveness.
Should I tell the insurance company when I start to receive treatment?
Unless your insurance company specifically requests that you advise them about treatment, after you have taken insurance cover, you do not have to tell the insurance company about any treatment you are taking.
However, if you later start a new policy, you will have to disclose the treatment you have had to the insurance company. It may be that receiving treatment affects the price of the premium in a positive way; remember if treatment is effective, insurance companies may take this into account when calculating your premium.
Why do insurance companies request information from your doctor or specialist?
Insurance companies may request medical information from your GP or hospital doctor to better understand your condition in order to accurately price the additional risk from any health problems you disclose.
What questions will the insurance company ask my General Practitioner or Specialist?
With your fully informed consent, insurance companies will usually send your GP or hospital doctor a ‘General Practitioners Report’ (GPR) which they will be required to complete.
General questions typically include topics such as:
Current health – are you receiving any medical care, medication, treatments.
Sickness record – have you taken days off work due to ill health.
Predictive genetic test results – must be disclosed only in the case of Huntington’s disease cases for life insurance policies over €500,000.
Can I ask my medical geneticist to explain my IRD, or does the insurance company only ask my doctor or specialist?
There is nothing to stop you from sending information to the insurance company from your medical geneticist. This may be helpful if you have a rare disease or condition which you feel the insurance company may not be familiar with.
What are my rights when an insurer is requesting information from my Doctor or specialist?
If a General Practitioner or hospital doctor report is requested, you will be asked for your fully informed consent, and there may be a question asking if you want to see a copy of the report before the GP sends it to the insurance company.
The insurance company will tell the GP or hospital doctor if you do want to see a copy of the report first. You are entitled to talk with your GP or hospital doctor before medical reports are sent to the insurance company you are entitled to know what information your GP or hospital doctor has provided to the insurance company.
Can insurance companies interpret my genetic tests results?
Yes. The interpretation will be carried out by a nominated senior insurance company staff member. They will refer to qualified medical experts for guidance whenever it is needed.
What if I have been refused insurance?
If you have been refused insurance, then you should contact your local Retina International member organisation.
Other links relevant to genetic discrimination and Insurance:
National Institute of Health: What is genetic discrimination?
FAQs about the genetic testing process
Information about the genetic test:
- What will actually happen when I or my child takes the test?
- Do other members of my family need to be tested?
- What will the test results tell me?
- Are there any risks in taking the test?
- How accurate is the test result?
- Will I definitely get a test result?
- How long will it take to get the test results?
- How will I receive the test results?
- Is the test going to cost me anything?
- Do I or my child have to take a genetic test or are there other ways of finding out the information I want to know?
- Who will the test results be given to?
Practical tools to support your education journey
What is Patient Experience
This RI task force aimed to develop consensus on policy priorities for AMD across three countries, identifying opportunities for collaboration and action at local, regional and global levels. Its deliverable was a set of policy recommendations for people living with AMD.
What is PPI
Patient and public involvement – commonly shortened to PPI – is a framework to give lay people an effective and active role in all forms of “healthcare research”.
Retina International Advocacy Toolkit (PDF)
This comprehensive resource has been designed to provide a framework for creating and implementing advocacy strategies – from picking your particular battle, gathering & generating the information (data) to support it, to deciding on the most effective lobbying avenues available to you.
Retina International Advocacy Toolkit (Word Format)
This comprehensive resource has been designed to provide a framework for creating and implementing advocacy strategies – from picking your particular battle, gathering & generating the information (data) to support it, to deciding on the most effective lobbying avenues available to you.
Living with a retinal condition?
Connect with 43 member organisations across 40+ countries.
-
close